APA (7th ed.) Citation

Y, X., J, M., Y, F., C, D., E, B., A, H., . . . Y, C. (2024). Author Correction: CBX3 antagonizes IFNγ/STAT1/PD-L1 axis to modulate colon inflammation and CRC chemosensitivity. EMBO molecular medicine, 16(10), 2652. https://doi.org/10.1038/s44321-024-00141-y

Chicago Style (17th ed.) Citation

Y, Xiang, et al. "Author Correction: CBX3 Antagonizes IFNγ/STAT1/PD-L1 Axis to Modulate Colon Inflammation and CRC Chemosensitivity." EMBO Molecular Medicine 16, no. 10 (2024): 2652. https://doi.org/10.1038/s44321-024-00141-y.

MLA (9th ed.) Citation

Y, Xiang, et al. "Author Correction: CBX3 Antagonizes IFNγ/STAT1/PD-L1 Axis to Modulate Colon Inflammation and CRC Chemosensitivity." EMBO Molecular Medicine, vol. 16, no. 10, 2024, p. 2652, https://doi.org/10.1038/s44321-024-00141-y.